Archive | Drugs RSS feed for this section

Why California’s Proposition 61 Was a Bad Idea

New approaches to control state pharmaceutical costs are needed.1 This issue is particularly critical in California, the state with the largest pharmaceutical expenditures in the country.1 A controversial California ballot initiative aimed at reining in prescription drug expenditures was defeated on November 8, 2016 by a 54% to 46% margin.2The California Drug Price Relief Act, also known […]

Read more
Osteoporosis

Western Osteoporosis Alliance Clinical Practice Series: Evaluating the Balance of Benefits and Risks of Long-Term

Osteoporosis is a chronic disease that requires life-long strategies to reduce fracture risk. Few trials have investigated the balance of benefits and risk with long-term use of osteoporosis therapies, and fewer still have investigated the consequences of treatment discontinuation. The best available evidence suggests that up to 10 years of treatment with an oral bisphosphonate […]

Read more

Hospital Admissions for Chest Pain Associated with Cocaine Use in the United States

The outcomes related to chest pain associated with cocaine use and its burden on the healthcare system are not well studied. Methods Data were collected from the Nationwide Inpatient Sample (2001-2012). Subjects were identified by using the International Classification of Diseases, Ninth Revision, Clinical Modification codes. Primary outcome was a composite of mortality, myocardial infarction, […]

Read more

Trends of Cannabis Use Disorder Among Inpatients (video)

As states legalize medical and recreational use of marijuana, hospitals are seeing an increase in inpatients who are marijuana users. The most common co-morbidities among marijuana users are psychiatric disease and alcoholism. There has been an increase in older, sicker patients using cannabis, most likely due to the advent of medical marijuana in many states. […]

Read more

Physician Exposure to Direct-to-Consumer Pharmaceutical Marketing

The American Medical Association’s 2015 recommendation to ban direct-to-consumer advertising (DTCA) of prescription drugs reflected a strong consensus that this form of marketing is a significant contributor to increased drug costs. It is well documented that many patients request drugs they have seen advertised on television and that physicians often acquiesce to these requests.1, 2, 3, 4 But the […]

Read more
UA-42320404-1